Aurubis AG (ETR:NDA) came out with its quarterly results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report. It was a credible result overall, with revenues of €5.0b and statutory earnings per share of €9.53 both in line with analyst estimates, showing that Aurubis is executing in line with expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.XTRA:NDA Earnings and Revenue Growth May 11th 2025

After the latest results, the eight analysts covering Aurubis are now predicting revenues of €19.3b in 2025. If met, this would reflect an okay 6.4% improvement in revenue compared to the last 12 months. Before this earnings report, the analysts had been forecasting revenues of €18.4b and earnings per share (EPS) of €6.32 in 2025. What's really interesting is that while the consensus made a small increase to revenue estimates, it no longer provides an earnings per share estimate. This suggests that revenues are now the focus of the business after this latest result.

View our latest analysis for Aurubis

There's been no real change to the consensus price target of €75.22, with Aurubis seemingly executing in line with expectations. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values Aurubis at €90.00 per share, while the most bearish prices it at €54.00. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Aurubis shareholders.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Aurubis' past performance and to peers in the same industry. It's clear from the latest estimates that Aurubis' rate of growth is expected to accelerate meaningfully, with the forecast 13% annualised revenue growth to the end of 2025 noticeably faster than its historical growth of 5.8% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 2.2% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Aurubis is expected to grow much faster than its industry.

Story Continues

The Bottom Line

The highlight for us was that the analysts increased their revenue forecasts for Aurubis next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. The consensus price target held steady at €75.22, with the latest estimates not enough to have an impact on their price targets.

We have estimates for Aurubis from its eight analysts out to 2027, and you can see them free on our platform here.

Before you take the next step you should know about the 2 warning signs for Aurubis (1 shouldn't be ignored!) that we have uncovered.

Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

View Comments